Efficacy and tolerance of an emollient+ on babies and children with Atopic Dermatitis: an observational study

A. Patsatsi, S. Salah, A.-L. Demessant Flavigny, D. Kerob

    La Roche-Posay
  • Jul 2024
  • 10min

25WCD2023_IMG


INTRODUCTION


Atopic dermatitis (AD) is one of the most prevalent inflammatory skin diseases, preferentially affecting children, with flares of inflammatory lesions and a permanent background of skin dryness. It is associated with itchy, red, swollen plaques and dry, cracked skin. This is a chronic condition where emollients, and Emollients+ are the foundation of treatment. Anti-inflammatory drugs (topicals/systemics) are recommended based on the severity of atopic dermatitis. One of the most documented consequences of AD on babies and children is a decrease in quality of sleep, this could lead, in the growing child, to difficulties in managing emotions and behavioral problems.

Join our community to read the full article

L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting edge research, science and education on skin and hair care.